Latest from Kromek

Kromek is pleased to announce a conditional Firm Placing, Directors’ Subscription and Open Offer to raise up to £13.0 million before expenses. The Firm Placing has been undertaken with new and existing institutional investors in the Company.

Kromek, alongside Newcastle Upon Tyne Hospitals NHS Foundation Trust (NuTH), are showcasing their early phase research in understanding the problem of dense breasts within breast cancer screening in the UK at the 2021 Symposium Mammographicum conference next week (7th - 10th Feb).

Kromek appeared on BBC Look North last night talking about our new biological threat detection system

Kromek announces that it has commenced a £1.25m programme funded by Innovate UK to customise its biological threat-detection solution for the automated detection of all airborne viruses, including COVID-19, to support end-use cases.

Kromek announces its interim results for the six months ended 31 October 2020.

Kromek is pleased to announce the appointment of Mr Berry Beumer, Chief Operating Officer (“COO”), as an Executive Director of the Group with immediate effect.